If you are:
FDB Only When Necessary: AVOID CHRONIC HIGH DOSE
FDB Contraindicated or Not Recommended: NO FDA CATEGORY; NOT RECOMMENDED ESPECIALLY IN 3RD TRIMESTER OR NEAR TERM
No Known Risk: POOR GI ABSORPTION
No Known Risk: EXCRETED IN ANIMAL STUDIES;POOR GI ABSORPTION
Absolute Contraindication: ONE REPORT OF METABOLIC ACIDOSIS; RISK OF REYE'S SYND IN VIRAL ILLNESS.
An adult over 60:
management or monitoring precaution: May cause constipation. Overuse may affect bone mineralization.
Giving Ascriptin tablet to a child under 12:
management or monitoring precaution: Rare risk of osteomalacia with high dose therapy.
Severe Precaution: Reye syndrome risk with viral illness, fever, and/or flu symptoms.
management or monitoring precaution: Not recommended as an antacid age < 2 years.